期刊文献+

恶性肿瘤并颈内或四肢静脉血栓形成危险因素分析 被引量:9

原文传递
导出
摘要 目的分析恶性肿瘤患者并发颈内静脉血栓栓塞(venous thromboembolism,VTE)及四肢VTE的危险因素。方法经血管彩色多普勒超声诊断的恶性肿瘤并VTE患者79例,依据血栓形成部位不同分为颈内VTE组36例和四肢VTE组43例,分析肿瘤特性与VTE的关系,并比较性别、肿瘤有无转移及淋巴结压迫等血栓形成危险因素。结果恶性肿瘤并颈内或四肢VTE与患者性别、肿瘤有无转移及局部淋巴结压迫有关(P<0.05);颈内VTE多见于男性,多数患者有局部淋巴结压迫症状;四肢VTE多见于女性,局部淋巴结压迫症状少见;颈内VTE多见于鳞癌患者,四肢VTE多见于腺癌患者。结论颈内及四肢静脉血栓形成与肿瘤组织病理类型、临床分期、病种及患者性别等有关;血管彩色多普勒超声可作为VTE首选检查方法。
出处 《中华实用诊断与治疗杂志》 2012年第11期1137-1138,共2页 Journal of Chinese Practical Diagnosis and Therapy
  • 相关文献

参考文献6

二级参考文献38

  • 1伍治平,王熙才,金从国,陈晓群,蒋永新,谷玉兰,陈艳.结直肠癌患者外周血血小板活化标志物检测及临床意义[J].中华肿瘤防治杂志,2006,13(13):1008-1010. 被引量:14
  • 2赵永强.易栓症研究概况[J].中国实用内科杂志,2007,27(1):49-52. 被引量:58
  • 3Lyman GH, Khorana AA, Falanga A, et al. American society of clinical oncology guideline : Recommendations for venous thrombolism prophylaxis and treatment in patients with cancer [J].J Clin Oncol, 2007, 25 : 5490.
  • 4Zacharski LR, Prandoni P, Monreal M, Warfarin versus low- molecular- weight heparin therapy in cancer patients [J]. The Oncologist, 2005, 10:72.
  • 5刘继周.病理学.北京:人民卫生出版社,1993,26.
  • 6Jarrett B P, Dougherty M J, Galligevo K D. Infevior vena cava filters in malignant disease[J]. Vasc Surg, 2002,36 (4) : 704-707.
  • 7Caine G J, Lip G Y, Stonelake P S, et al. Platelet activation, coagulation and angiogenesis in breast and prostate carcinomaE[J]. Thromb Haemost, 2004, 92(1):185-190.
  • 8陈曦,欧阳学农,陈樟树.癌症合并血栓形成研究概况[J].国外医学(肿瘤学分册),1997,24(2):108-110. 被引量:49
  • 9Khorana A A, Francis C W, Culakova E, et al.Thron, bocmbolism in hospitalized neutropenic cancer patients [J]. J Clin Oncol, 2006,24(3) :484 -490.
  • 10Korte W. Cancer and thrombosis: an increasingly important association[J]. Support Care Cancer,2008,16(3):223 -228.

共引文献30

同被引文献77

  • 1何杏洪,陈晓曼,张锦笑.气压治疗仪预防剖宫产术后下肢深静脉血栓的疗效观察[J].医学信息(医学与计算机应用),2014,0(31):69-70. 被引量:2
  • 2类健翔,陈平,汤翠菊.瑞血新对同步放化疗后骨髓抑制的作用[J].中国现代医学杂志,2005,15(3):390-391. 被引量:2
  • 3孙燕,石远凯.内科肿瘤学[M].北京:人民卫生出版社,2007:785-788.
  • 4殷尉伯,谷铣之.肿瘤放射治疗学[M].北京:中国协和医科大学出版社,2002:1088-1090.
  • 5Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment insolid tumors European Organiza- tion for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. [J]. J Natl Cancer Inst, 2000, 92(3): 205-216.
  • 6Liu Yang-fan. Clinical observation ofburnet root leukopoietic tablets prevent for radiotherapy leukopenia[J]. Chin J Mod Drug Appl, 2011, 5(10): 88-89.
  • 7实用肿瘤内科学[M]. 人民卫生出版社, 2003.实用肿瘤内科学[M]人民卫生出版社,2003.
  • 8Hardt J,Schwarzbach M,Hasenberg T.The effect of a clinical pathway for enhanced recovery of rectal resections on perioperative quality of care. International Journal of Colorectal Disease . 2013
  • 9Korte W. Cancer and thrombosis: an increasingly important association [ J] .Support Care Cancer, 2008,16 ( 3 ) : 315. doi: 10.1007/s00520-007-0376-y.
  • 10Peronnet E, Becquart L, Poirier F, et al.SELDI-TOF MS analysis of the Cardiac Troponin I forms present in plasma from patients with myocardial infarction [ J].Proteomics,2006,6(23) :6288-6299.

引证文献9

二级引证文献98

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部